Source: News Brig

Amarex Clinical Research: Kazem Kazempour, CEO of Germantown biotech firm Amarex, charged with securities fraud

Kazem Kazempour, CEO of Germantown biotech firm Amarex, charged with securities fraud The post Kazem Kazempour, CEO of Germantown biotech firm Amarex, charged with securities fraud appeared first on NEWS BRIG.

Read full article »
Amarex Clinical Research's Competitors | Amarex Clinical Research's News | Amarex Clinical Research's Financials
Stay up-to-date with the latest news on Amarex Clinical Research
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Kazem Kazempour's photo - President & CEO of Amarex Clinical Research

President & CEO

Kazem Kazempour

CEO Approval Rating

69/100

Read more
Stay up-to-date with the latest news on Amarex Clinical Research